Literature DB >> 7005688

Reversible activation-inactivation of renin in human plasma.

B J Leckie, N K McGhee.   

Abstract

Renin, an aspartate protease, cleaves the alpha-globulin angiotensinogen to produce the decapeptide angiotensin I, which is then converted to the vasoactive hormone angiotensin II by the action of a peptidase 'converting enzyme'. An inactive form of renin sometimes termed prorenin is present in normal human plasma. Its enzymatic activity is increased by exposure to a pH of 3.0 or 3.3 followed by dialysis towards neutral pH. Only a small proportion of the inactive renin is activated during the acid stage of dialysis, most of the activation apparently taking place during the subsequent dialysis to pH 5.7 (ref. 4) or 7.5 (ref. 5). Furthermore, if inhibitors of serine proteases are added to the plasma, the amount of inactive renin activated by this dialysis procedure is reduced. These results suggest that acid-activation is mediated by serine proteases. The role of enzymes such as plasma kallikrein, plasmin and renal kallikrein as physiological activators of inactive renin has recently been discussed. In our study of the activation of plasma inactive renin we have no found that, contrary to previous reports, complete activation of inactive renin takes place during the acid stage of dialysis. This activation can be reversed if plasma is rapidly adjusted to pH 7.4 and warmed. The next step in the acid-activation procedure, that is, dialysis to neutral pH, renders the initial acid-activation irreversible. These results were completely unexpected, and we offer an explanation that reassesses the nature of inactive renin and the activation process.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7005688     DOI: 10.1038/288702a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  5 in total

1.  Renin and cardiovascular disease: Worn-out path, or new direction.

Authors:  Gaurav Alreja; Jacob Joseph
Journal:  World J Cardiol       Date:  2011-03-26

2.  Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.

Authors:  M Véniant; J Ménard; P Bruneval; S Morley; M F Gonzales; J Mullins
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Characterization of inactive renin ("prorenin") from renin-secreting tumors of nonrenal origin. Similarity to inactive renin from kidney and normal plasma.

Authors:  S A Atlas; T E Hesson; J E Sealey; B Dharmgrongartama; J H Laragh; M C Ruddy; M Aurell
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

4.  Characterization of inactive renin from human kidney and plasma. Evidence of a renal source of circulating inactive renin.

Authors:  W A Hsueh; E J Carlson; V J Dzau
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

5.  Activation mechanism of plasmepsins, pepsin-like aspartic proteases from Plasmodium, follows a unique trans-activation pathway.

Authors:  Ishan Rathore; Vandana Mishra; Chandan Patel; Huogen Xiao; Alla Gustchina; Alexander Wlodawer; Rickey Y Yada; Prasenjit Bhaumik
Journal:  FEBS J       Date:  2020-05-26       Impact factor: 5.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.